Recently, Scialla et al. reported that higher FGF-23 level was independently associated with greater risk of CV events, particularly CHF, in a prospective cohort of 3,860 participants with CKD stages 2–4 (91). The gene discussed is FGF23; the disease is chronic kidney disease.